Freenome

freenome.com

Freenome is a biotech company focused on early cancer detection through a novel screening platform that combines multiomics technology and artificial intelligence. Their approach allows for the detection of cancer in its earliest and most treatable stages using a simple blood draw. With a commitment to rigorous clinical research and a values-driven culture, Freenome aims to redefine cancer screening and improve patient outcomes. The company has established itself in the market with a clear vision and a dedicated team, positioning itself as a leader in the early detection of cancer.